MUCOCUTANEOUS LEISHMANIASIS AND HIV

Mucocutaneous leishmaniasis is a rare disease in Europe. Relapses afte r treatment are more frequent than in visceral leishmaniasis. HIV pati ents infected by Leishmania have frequently visceral involvement, and responses to treatment are poor. Mucocutaneous leishmaniasis in HIV-in fected patients has rarely been reported. A patient with centrofacial granuloma was diagnosed as having mucocutaneous leishmaniasis; simulta neously HIV infection was detected. To our knowledge this is the first case acquired in Europe. Intravenous meglumine antimonate 20 mg/kg/da y for 28 days was proven to be useful.